Scientist Paul Greengard has discovered a hopefully, major breakthrough with an alzheimer's drug. He has discovered a new protein needed to make beta amyloid. Beta Amyloid is a plaque build up in the brain of alzheimer patients. The new finding reveals a drug target that could slow down the affects of alzheimers on the brain.
Greengard became interested in researching a cure for alzheimer's after his father in law was diagnosed with the disease 25 years ago. His research has been funded by federal grants and funds.
To view the whole article visit http://www.nytimes.com/2010/09/02/health/research/02alzheimer.html
If you are 65 years or older or you have a family member that is please visit our site at http://www.texasmedigapselect.com/ for information on all your options when it comes to medicare supplements.
We at the Fisher Center for Alzheimer’s Research Foundation are very proud to have funded this tremendous new finding of Dr. Paul Greengard. For the past 15 years, we have been proud to support the good work of Dr. Greengard and his internationally renowned team of scientists at The Fisher Center for Alzheimer’s Disease Research. We would like to specifically congratulate Drs. He and Greengard for discovering this important protein. Their latest research is a potential paradigm shift in how scientists and doctors around the world will attack Alzheimer’s. Kent L. Karosen, President and CEO Fisher Center for Alzheimer’s Research Foundation www.alzinfo.org
ReplyDelete